Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Carefirst Caremark / Praluent Alirocumab

Praluent Alirocumab — Carefirst Caremark

4 indications indexed for this drug.

Clinical Atherosclerotic Cardiovascular Disease Ascvd
View coverage criteria
Familial Hypercholesterolemia Heterozygous Or Homozygous
View coverage criteria
Homozygous Familial Hypercholesterolemia Hofh
View coverage criteria
Primary Hyperlipidemia
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.